FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.
U.S. to spend $3.2 billion to help develop antiviral pills for COVID-19
Jun 18, 2021
Oral medications patients take when symptoms first appear are being tested, but initial results are not expected for several months.
Biden to announce plan to battle omicron, delta variants this winter
Dec 02, 2021
The strategy will include free tests, extending rules on mask wearing and launching public awareness campaigns.
FDA panel mulls Merck COVID-19 antiviral pill
Nov 30, 2021
An expert panel will vote later Tuesday on whether to recommend authorizing the drug for high-risk patients.
Mentalizing imagery therapy aids family caregivers
Mar 24, 2022
The findings show lower depression and anxiety and better well-being versus support group attendance.
Uptake low for monoclonal antibodies for COVID-19
Sep 22, 2021
Use peaked in January and declined in early 2021, at the time of the vaccine rollout.
U.S. to recommend booster shots for most Americans
Aug 17, 2021
The first boosters will be given to nursing home residents, healthcare workers and emergency workers. U.S. health officials are concerned as data from Israel continue to suggest that the Pfizer vaccine’s...
Melatonin aids sleep in older adults
May 25, 2022
A 5-mg dose of melatonin was found to improve sleep in both the biological daytime and nighttime.
Biden plans to send 400 million N95 masks to Americans for free
Jan 19, 2022
The move follows updated mask guidance issued by the CDC late last week.
U.S. begins targeted vaccine rollout against monkeypox
Jun 29, 2022
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine.